Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cartomerge Versus NavX Fusion in Catheter Ablation of Atrial Fibrillation (CAVERN)

This study has been completed.
Information provided by (Responsible Party):
Dr Richard Schilling, Barts & The London NHS Trust Identifier:
First received: February 21, 2011
Last updated: September 12, 2011
Last verified: September 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2011
  Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):